August 2019 FDA Recall Drug by Remedyrepack Inc.
D-1030-2020 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on August 5, 2019 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed in PA and the recall is currently terminated.

Recall Number: D-1030-2020

Reason for Recall
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Initiated
08-05-2019
Reported
03-25-2020
Quantity
480 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).

Batch or Lot Expiration Information

Lot# : J0322819-091418, Exp: 09/30/2019